{
  "trial_id": "NCT02942407",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, CHA2DS2-VASc score, duration of hemodialysis, baseline hemoglobin level, history of intracranial hemorrhage, history of gastrointestinal bleed, history of retroperitoneal bleed, hepatic function, pregnancy status, use of aspirin, use of P2Y12 antagonist therapy, life expectancy, anticipated kidney transplant status, incarceration status, participation in other clinical trials.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Male",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Weight"
      ],
      "remaining_candidate_features": [
        "CHA2DS2-VASc score",
        "duration of hemodialysis",
        "baseline hemoglobin level",
        "history of intracranial hemorrhage",
        "history of gastrointestinal bleed",
        "history of retroperitoneal bleed",
        "hepatic function",
        "pregnancy status",
        "use of aspirin",
        "use of P2Y12 antagonist therapy",
        "life expectancy",
        "anticipated kidney transplant status",
        "incarceration status",
        "participation in other clinical trials."
      ]
    },
    "processed-gen-response": "Age, gender, CHA2DS2-VASc score, duration of hemodialysis, baseline hemoglobin level, history of intracranial hemorrhage, history of gastrointestinal bleed, history of retroperitoneal bleed, hepatic function, pregnancy status, use of aspirin, use of P2Y12 antagonist therapy, life expectancy, anticipated kidney transplant status, incarceration status, participation in other clinical trials."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, CHA2DS2-VASc score, Duration of Hemodialysis, Baseline Hemoglobin, Baseline Serum Creatinine, Baseline eGFR, History of Intracranial Hemorrhage, History of Gastrointestinal Bleed, History of Retroperitoneal Bleed, Baseline Liver Function Tests, Use of Aspirin, Use of P2Y12 Antagonist Therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "CHA2DS2-VASc score",
        "Duration of Hemodialysis",
        "Baseline Hemoglobin",
        "Baseline Serum Creatinine",
        "Baseline eGFR",
        "History of Intracranial Hemorrhage",
        "History of Gastrointestinal Bleed",
        "History of Retroperitoneal Bleed",
        "Baseline Liver Function Tests",
        "Use of Aspirin",
        "Use of P2Y12 Antagonist Therapy"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, CHA2DS2-VASc score, Duration of Hemodialysis, Baseline Hemoglobin, Baseline Serum Creatinine, Baseline eGFR, History of Intracranial Hemorrhage, History of Gastrointestinal Bleed, History of Retroperitoneal Bleed, Baseline Liver Function Tests, Use of Aspirin, Use of P2Y12 Antagonist Therapy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, CHA2DS2-VASc score, Hemodialysis duration, History of bleeding, History of stroke or systemic embolism, History of myocardial infarction, History of peripheral artery disease, History of hypertension, History of diabetes, History of heart failure,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "CHA2DS2-VASc score",
        "Hemodialysis duration",
        "History of bleeding",
        "History of stroke or systemic embolism",
        "History of myocardial infarction",
        "History of peripheral artery disease",
        "History of hypertension",
        "History of diabetes",
        "History of heart failure"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, CHA2DS2-VASc score, Hemodialysis duration, History of bleeding, History of stroke or systemic embolism, History of myocardial infarction, History of peripheral artery disease, History of hypertension, History of diabetes, History of heart failure"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), CHA2DS2-VASc score, duration of atrial fibrillation, duration of hemodialysis, type of hemodialysis access, hemoglobin, creatinine, estimated glomerular filtration rate (eGFR), liver function tests, history of bleeding, history of stroke or transient ischemic attack, history of myocardial infarction, history of peripheral artery disease, history of intracranial hemorrhage, history of gastrointestinal bleed or retroperitoneal bleed, use of antiplatelet agents, use of non-steroidal anti-inflammatory drugs (NSAIDs).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Weight",
          "weight"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "height",
        "body mass index (BMI)",
        "CHA2DS2-VASc score",
        "duration of atrial fibrillation",
        "duration of hemodialysis",
        "type of hemodialysis access",
        "hemoglobin",
        "creatinine",
        "estimated glomerular filtration rate (eGFR)",
        "liver function tests",
        "history of bleeding",
        "history of stroke or transient ischemic attack",
        "history of myocardial infarction",
        "history of peripheral artery disease",
        "history of intracranial hemorrhage",
        "history of gastrointestinal bleed or retroperitoneal bleed",
        "use of antiplatelet agents",
        "use of non-steroidal anti-inflammatory drugs (NSAIDs)"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), CHA2DS2-VASc score, duration of atrial fibrillation, duration of hemodialysis, type of hemodialysis access, hemoglobin, creatinine, estimated glomerular filtration rate (eGFR), liver function tests, history of bleeding, history of stroke or transient ischemic attack, history of myocardial infarction, history of peripheral artery disease, history of intracranial hemorrhage, history of gastrointestinal bleed or retroperitoneal bleed, use of antiplatelet agents, use of non-steroidal anti-inflammatory drugs (NSAIDs)."
  }
}